Our site may be slower due to heavy traffic from automated "bots" and AI crawlers. We're working to fix this.

Brian Anderson, MD

Photo of Brian Anderson, MD
Title(s)Associate Professor, Psychiatry
SchoolSchool of Medicine
Address1001 Potrero Avenue, #001
San Francisco CA 94110
PronounsHe/Him/His
vCardDownload vCard

    Collapse Biography 
    Collapse education and training
    San Francisco VA Medical CenterPostdoctoral Research Fellowship2018-20Advanced Neurosciences
    UCSFResidency2015-18Psychiatry
    UCSFInternship2014-15Psychiatry
    StanfordMD2008-14School of Medicine
    London School of EconomicsMSc2010-11Sociology
    University of PennsylvaniaBA2003-07Biochemistry
    Collapse awards and honors
    UCSF Department of Psychiatry2018Academic Scholarship Award
    SFGH2015Krevans Award for Patient Care
    Society for Medical Anthropology ADTSG2011Annual Student Paper Prize

    Collapse Overview 

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Featured Publications

    Collapse Featured Content 
    Collapse Collaboration Interests

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Trends in first-time psychedelic and other hallucinogen use in the United States: Results from the National Survey on Drug Use and Health. Drug Alcohol Depend. 2026 Feb 20; 282:113059. Montoy JCC, Wang RC, Coker AR, Anderson BT. PMID: 41795251.
      View in: PubMed   Mentions:
    2. Indigenous Knowledge Systems & Psychedelic Science: Towards Ethical and Reciprocal Collaboration. J Psychopharmacol. 2026 Jan 30; 2698811251387104. Magar V, Robbins M, Fernández Lobo Blanco ÓML, Ali IL, Anderson B, Grob C, Henningfield JE, Kryskow P, Kuiper H, Loizaga-Velder A, Rush B, Volat M, Iron Rope S. PMID: 41618525.
      View in: PubMed   Mentions:    Fields:    
    3. Psychedelic Augmentation of 12-Step Engagement: A Novel, Accessible Approach to Enhance Community-Based Recovery from Substance Use Disorders. J Psychoactive Drugs. 2025 Nov 10; 1-10. Mehtani NJ, Mian MN, Agin-Liebes G, Coker AR, Huebner C, Anderson BT, Mitchell JM. PMID: 41214462; PMCID: PMC12646296.
      View in: PubMed   Mentions:    Fields:    
    4. Meaning and Psychedelics in Palliative Care: A Narrative Review. J Pain Symptom Manage. 2026 Mar; 71(3):e299-e321. Alexander WB, Hansen ED, Anderson BT, Zarrabi AJ, Rogers AH, Loewen G, Ficarro ZR, Alexander MH, Schaefer D, Case AA. PMID: 41173063.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. US Poison Center Encounters for Psilocybin-Related Exposures: 2013-2022. J Am Coll Emerg Physicians Open. 2025 Oct; 6(5):100231. Montoy JCC, Wang RC, Coker AR, Smollin CG, Anderson BT. PMID: 40927687; PMCID: PMC12414881.
      View in: PubMed   Mentions:
    6. Ketamine-Assisted Recovery (KARE): protocol for an open-label pilot trial of ketamine-assisted psychotherapy for publicly insured patients with methamphetamine use disorder and HIV risks. BMJ Open. 2025 Aug 24; 15(8):e100775. Mehtani NJ, Anderson BT, Alexander I, Hendricks PS, Mitchell JM, Coffin PO, Johnson MO. PMID: 40850924; PMCID: PMC12382537.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    7. Latent Classes of Lifetime Use of Seven Hallucinogens in the United States. J Psychoactive Drugs. 2025 Aug 04; 1-7. Meacham MC, Mian MN, Wang RC, Coker AR, Anderson BT, Montoy JCC. PMID: 40760833.
      View in: PubMed   Mentions:    Fields:    
    8. A model training curriculum for psychedelic, psycholytic, and entactogen-assisted psychotherapy. J Psychopharmacol. 2025 Jun 10; 2698811241282759. Passie T, Loizaga-Velder A, Danforth A, Grob CS, Greer GR, Erritzoe D, Oehen P, Styk J, Schlichting M, Vermetten E, Goksøyr IW, Palenicek T, Mithoefer MC, Mithoefer A, Anderson B, Krediet E, Gasser P, Nielson EM, Gorman I, Phelps J, Belser AB, Guss J. PMID: 40492498.
      View in: PubMed   Mentions: 1     Fields:    
    9. A systematic review of income and education reporting in psychedelic clinical trials. Nat Ment Health. 2025 May; 3(5):567-574. Grossman DH, Madden KM, Mehtani NJ, Anderson BT, Davis LL, Mitchell JM, Hendricks PS. PMID: 41773283; PMCID: PMC12950257.
      View in: PubMed   Mentions:
    10. On Minimizing Risk and Harm in the Use of Psychedelics. Psychiatr Res Clin Pract. 2025; 7(1):4-8. Evans J, Aixalà M, Anderson BT, Brennan W, Bremler R, Breeksema JJ, Burback L, Calder AE, Carhart-Harris RL, Cheung K, Devenot N, Gorman I, Gren J, Hendricks PS, Holoyda B, Jacobs E, Krecké J, Kruger DJ, Luke D, Majic T, McGuire AL, Mehtani NJ, Mathai DS, Nash K, Noorani T, Palitsky R, Robinson OC, Simonsson O, Stahre E, van Elk M, Yaden DB. PMID: 40171068; PMCID: PMC11956720.
      View in: PubMed   Mentions: 3  
    11. Psychedelic Regulation Beyond the Controlled Substances Act: A Three-Dimensional Framework for Characterizing Policy Options. Am J Psychiatry. 2025 Jan 01; 182(1):6-9. Mian MN, Dinh MT, Coker AR, Mitchell JM, Anderson BT. PMID: 39741445; PMCID: PMC11772052.
      View in: PubMed   Mentions: 2     Fields:    
    12. Implementation of the California End of Life Option Act at UCSF: Examining the Utility of the Mandatory Mental Health Assessment in Medical Aid in Dying. J Acad Consult Liaison Psychiatry. 2025 Mar-Apr; 66(2):172-178. Dinh MT, Bell B, Bourgeois JA, Weaver E, Martin J, O'Riordan DL, Rabow M, Kaplan L, Kaplan L, Anderson B. PMID: 39615629.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. Psilocybin-assisted therapy and HIV-related shame. Sci Rep. 2024 08 02; 14(1):17919. Mehtani NJ, Johnson MO, Hendricks PS, Mitchell J, Anderson BT. PMID: 39095420; PMCID: PMC11297300.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    14. Older adults in psychedelic-assisted therapy trials: A systematic review. J Psychopharmacol. 2024 Jan; 38(1):33-48. Bouchet L, Sager Z, Yrondi A, Nigam KB, Anderson BT, Ross S, Petridis PD, Beaussant Y. PMID: 38240068.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    15. Psychedelics in Addiction Treatment-Navigating a Sociopolitical Rift. JAMA Neurol. 2024 Jan 16. Mehtani NJ, Anderson BT, Mitchell JM. PMID: 38227310; PMCID: PMC12826034.
      View in: PubMed   Mentions: 2     Fields:    
    16. Misinterpretations and Omissions: A Critical Response to Goodwin and Colleagues' Commentary on Psilocybin-Assisted Therapy. Am J Psychiatry. 2024 Jan 01; 181(1):74-75. O'Donnell KC, Anderson BT, Barrett FS, Bogenschutz MP, Grob CS, Hendricks PS, Kelmendi B, Nayak SM, Nicholas CR, Paleos CA, Stauffer CS, Gukasyan N. PMID: 38161295.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    17. Psychedelic Science, Contemplative Practices, and Indigenous and Other Traditional Knowledge Systems: Towards Integrative Community-Based Approaches in Global Health. J Psychoactive Drugs. 2023 Nov-Dec; 55(5):523-538. Urrutia J, Anderson BT, Belouin SJ, Berger A, Griffiths RR, Grob CS, Henningfield JE, Labate BC, Maier LJ, Maternowska MC, Weichold F, Yaden DB, Magar V. PMID: 37747281.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    18. Psychedelic Research and Therapeutic Practices: Embracing Communities, Groups, and Traditional Knowledge. J Psychoactive Drugs. 2023 Nov-Dec; 55(5):519-522. Magar V, Urrutia J, Anderson BT. PMID: 37842876.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    19. Psychedelic therapies reconsidered: compounds, clinical indications, and cautious optimism. Neuropsychopharmacology. 2024 Jan; 49(1):96-103. Mitchell JM, Anderson BT. PMID: 37479859; PMCID: PMC10700471.
      View in: PubMed   Mentions: 14     Fields:    
    20. Commentary: Evidence-Informed Recommendation to Achieve Approximate Parity in the Allowed Number of Doses for Common Psychedelics. J Psychoactive Drugs. 2024 Apr-Jun; 56(2):206-210. Thomas KL, Jesse R, Mehtani NJ, Mitchell JM, Anderson BT. PMID: 37061961.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    21. Policy considerations that support equitable access to responsible, accountable, safe, and ethical uses of psychedelic medicines. Neuropharmacology. 2022 11 15; 219:109214. Belouin SJ, Averill LA, Henningfield JE, Xenakis SN, Donato I, Grob CS, Berger A, Magar V, Danforth AL, Anderson BT. PMID: 35973601; PMCID: PMC9536012.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    22. If the Doors of Perception Were Cleansed, Would Chronic Pain be Relieved? Evaluating the Benefits and Risks of Psychedelics. J Pain. 2022 10; 23(10):1666-1679. Dworkin RH, Anderson BT, Andrews N, Edwards RR, Grob CS, Ross S, Satterthwaite TD, Strain EC. PMID: 35643270.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    23. Special considerations for evaluating psilocybin-facilitated psychotherapy in vulnerable populations. Neuropharmacology. 2022 08 15; 214:109127. Ortiz CE, Dourron HM, Sweat NW, Garcia-Romeu A, MacCarthy S, Anderson BT, Hendricks PS. PMID: 35577136.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    24. Comment and Response: (Lugo-Radillo & Cortez-Lopez, 2020) Long-Term Amelioration of OCD Symptoms in a Patient with Chronic Consumption of Psilocybin-Containing Mushrooms. J Psychoactive Drugs. 2022 Sep-Oct; 54(4):324-327. Fitzpatrick CM, Anderson BT, Agin-Liebes G, Guydish J. PMID: 35083957.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    25. The Potential of Psychedelics for End of Life and Palliative Care. Curr Top Behav Neurosci. 2022; 56:169-184. Yaden DB, Nayak SM, Gukasyan N, Anderson BT, Griffiths RR. PMID: 34958455.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    26. Psilocybin-Assisted Group Therapy and Attachment: Observed Reduction in Attachment Anxiety and Influences of Attachment Insecurity on the Psilocybin Experience. ACS Pharmacol Transl Sci. 2021 Apr 09; 4(2):526-532. Stauffer CS, Anderson BT, Ortigo KM, Woolley J. PMID: 33860182; PMCID: PMC8033604.
      View in: PubMed   Mentions: 26  
    27. Psychedelic medicine: safety and ethical concerns. Lancet Psychiatry. 2020 10; 7(10):829-830. Anderson BT, Danforth AL, Grob CS. PMID: 32949507.
      View in: PubMed   Mentions: 35     Fields:    
    28. Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study. EClinicalMedicine. 2020 Oct; 27:100538. Anderson BT, Danforth A, Daroff PR, Stauffer C, Ekman E, Agin-Liebes G, Trope A, Boden MT, Dilley PJ, Mitchell J, Woolley J. PMID: 33150319; PMCID: PMC7599297.
      View in: PubMed   Mentions: 89  
    29. Psychedelic-Assisted Group Therapy: A Systematic Review. J Psychoactive Drugs. 2019 Apr-Jun; 51(2):174-188. Trope A, Anderson BT, Hooker AR, Glick G, Stauffer C, Woolley JD. PMID: 30950777; PMCID: PMC6650145.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    30. Violence, addiction, recovery: An anthropological study of Mexico's anexos. Transcult Psychiatry. 2016 08; 53(4):445-64. Garcia A, Anderson B. PMID: 27535824; PMCID: PMC5531188.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    31. 'Spirituality' and 'cultural adaptation' in a Latino mutual aid group for substance misuse and mental health. BJPsych Bull. 2015 Aug; 39(4):191-5. Anderson BT, Garcia A. PMID: 26755953; PMCID: PMC4706138.
      View in: PubMed   Mentions: 3  
    32. The Therapeutic Use of Ayahuasca (Labate & Cavnar, Eds). Healing with Yagé: An Interview with Taita Juan Bautista Agreda Chindoy. 2014; 197-215. Anderson, Brian T., Beatriz Caiuby Labate, and Celina M. De Leon .
    33. Statement on ayahuasca. Int J Drug Policy. 2012 May; 23(3):173-5. Anderson BT, Labate BC, Meyer M, Tupper KW, Barbosa PC, Grob CS, Dawson A, McKenna D. PMID: 22459485.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimals
    34. Ayahuasca as antidepressant? Psychedelics and styles of reasoning in psychiatry. Anthropology of Consciousness. 2012; 23(1):44-59. Anderson, Brian T. View Publication.
    35. Ayahuasca, ritual and religion in Brazil (Labate & MacRae, Eds). The treatment and handling of substance dependence with ayahuasca: Reflections on current and future research. 2010; 205-227. Labate, B. C., Santos, R. G., Anderson, B., Mercante, M., & Barbosa, P. C. R.
    36. Enhanced sensitivity of the MRL/MpJ mouse to the neuroplastic and behavioral effects of chronic antidepressant treatments. Neuropsychopharmacology. 2009 Jun; 34(7):1764-73. Balu DT, Hodes GE, Anderson BT, Lucki I. PMID: 19177066; PMCID: PMC2680932.
      View in: PubMed   Mentions: 37     Fields:    Translation:AnimalsCells
    37. Psychedelic Psychotherapy: The Ethics of Medicine for the Soul. Penn Bioethics Journal. 2006; 2(1). Anderson, Brian .
    Brian's Networks
    Concepts (82)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (20)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-21-g9d46e6c4 on PROFILES-PWEB04.

    Copyright © The Regents of the University of California.